1. Zargari A. Medicinal plants (6th ed). University of Tehran Press. 2016, 574-8.
2. Hyman SE and Malenka RC. Addiction and the brain: the neurobiology of compulsion and persistence. Nat. Rev. Neurosci. 2001; 2(10): 695-703. [
DOI:10.1038/35094560]
3. De Vries TJ and Shippenberg TS. Neural systems underlying opiate addiction. J. Neurosci. 2002; 22(9): 3321-5. [
DOI:10.1523/JNEUROSCI.22-09-03321.2002]
4. Cami J and Farre M. Drug addiction. N. Engl. Med. 2003; 349(10): 975-86. [
DOI:10.1056/NEJMra023160]
5. Nestler EJ. Molecular basis of long-term plasticity underlying addiction. Nat. Rev. Neurosci. 2(2): 119-28. [
DOI:10.1038/35053570]
6. Robinson TE and Berridge KC. Addiction. Annu Rev. Psychol. 2013; 54: 25-53. [
DOI:10.1146/annurev.psych.54.101601.145237]
7. Makri A and Norouzi A. The guide on methadone maintenance treatment in addicts. Irsa Publications. 2013.
8. Center for Substance Abuse Treatment. Substance Abuse Treatment for Persons with Co-Occurring Disorders. Treatment Improvement Protocol (TIP) Series. 2015.
9. Talebi Kaysari, Fatemeh; Milladi, Hussein; Effect of Medicinal Plants on the Treatment of Morphine Addiction; Review of Laboratory Studies. Journal of North Khorasan University of Medical Sciences 2012; 4: 157-64. [
DOI:10.29252/jnkums.4.5.S5.157]
10. Vlogg Studola J. Medicinal Plants, 1997, p: 3-231-6.
11. Mohammad Nemat Shahi, Atefeh Asadi, Elham Behnam Talab, Mahbobeh Nemat Shahi. Clinical Study The Impact of Saffron on Symptoms of Withdrawal Syndrome in Patients Undergoing Maintenance Treatment for Opioid Addiction in Sabzevar Parish in 2017; Hindawi Advances in Medicine; Volume 2017, Article ID 1079132, 5 pages [
DOI:10.1155/2017/1079132]
12. Dehghan G and et al. The study of mode of action of Berberis vulgaris in the reduce of morphine withdrawal syndrome signs in the male mouse. Abst of the 10 th Iranian Congress of Physiology and Pharmacology. 2013.
13. Tavakoli M, Sahaf R, Farhudian A, Bakhtavar Y and Farhadi M. The influence of detoxification on the quality of life in substance addicts lives with 40-65 years of age referring to the charity. Salmand-e - Iranian J. 2012; 6: 34-40. (Persian)
14. Salehi M; Mikehlf A, Barkatin Majid. The effect of amitriptyline on the control of acute withdrawal symptoms of opiates. Journal of Semnan University of Medical Sciences 2005; 6 (3): 195-200.
15. Hojjati H, Aloustani S, Akhondzadeh G, Heidari B and Sharif-Nia H. Study of mental health and its relation with quality of life in addicts. J. Shahid Sadoughi Uni. Med. Sci. 2010; 18: 207-14. (Persian)
16. Nassiriasl Marjan. Effect of "Release" and "Burberry" in toxic and non-toxic doses in reducing the symptoms of morphine withdrawal syndrome in mice; http://crs.qums.ac.ir/webdocument/load.action?webdocument_code=1000&masterCode=14000455#h4.
17. Esmaeili MH, Azhdarea H, haghdoost H, sofiabadea M. Effect of orexin receptor-1 agonist and antagonist microinjection into the ventral tegmental area on morphine withdrawal syndrome. J. Qazvin Univ. Med. Sci. 2013; 17(3): 4-11.